Data is currently being updated. Some features may be temporarily unstable.

Disease Profile

Bacterial

Psittacosis

鹦鹉热

Psittacosis is a zoonotic bacterial infection caused by Chlamydia psittaci, primarily transmitted to humans through inhalation of aerosolised bird droppings or respiratory secretions. While many infections present as mild influenza-like illness, the disease can progress to severe atypical pneumonia with systemic complications. Bird-to-human transmission remains the dominant pathway, with psittacine birds and other poultry serving as natural reservoirs. No human vaccine exists, making exposure prevention the cornerstone of public health control.

Definition

Psittacosis, also known as parrot fever or ornithosis, is a zoonotic infectious disease caused by the obligate intracellular bacterium Chlamydia psittaci. The disease derives its name from the primary reservoir—psittacine birds such as parrots, parakeets, cockatiels, and budgerigars—though infection has been documented across a broad range of avian species including pigeons, turkeys, chickens, and ducks. The organism establishes infection in birds, many of which may remain asymptomatic while shedding bacteria in feces and respiratory secretions for prolonged periods, creating ongoing environmental contamination that poses transmission risk to humans.

Clinical features

The clinical spectrum of psittacosis ranges from completely asymptomatic infection to life-threatening atypical pneumonia. The incubation period typically spans 5 to 14 days, though delayed symptom onset has been reported. Most patients present with a characteristic symptom complex including fever, chills, headache, myalgia, and a non-productive cough; some individuals develop progressive shortness of breath indicative of lower respiratory involvement. Less common manifestations include gastrointestinal symptoms, rash, splenomegaly, and pulse-temperature dissociation. Chest imaging typically reveals lobar or interstitial infiltrates in patients with pneumonia. Severe complications, though uncommon, encompass hepatitis, encephalitis, endocarditis, and other neurologic sequelae, underscoring the disease's potential for systemic involvement beyond the respiratory tract.

Epidemiology

Psittacosis occurs worldwide wherever humans maintain close contact with infected birds, whether through pet ownership, poultry handling, or occupational exposure in aviculture and veterinary settings. The disease maintains a persistent but typically low-incidence profile in surveillance systems, partly due to diagnostic challenges and underrecognition. Birds serve as the primary reservoir, and infection pressure correlates with environments where aerosolised contaminated dust accumulates—such as poorly ventilated bird housing facilities, pet shops, and poultry processing environments. The absence of person-to-person transmission and the lack of foodborne spread through poultry products limit outbreak amplification, though sporadic cases and occupational clusters continue to be reported in settings with inadequate exposure controls.

Transmission

Human infection predominantly occurs through inhalation of aerosolised particles containing Chlamydia psittaci, originating from dried bird droppings or respiratory secretions of infected birds. This airborne route accounts for the majority of documented cases and explains the occupational risk to bird handlers, pet shop workers, and poultry industry personnel. Less frequent transmission pathways include direct bird bites and beak-to-mouth contact, though these represent minor contributors to overall disease incidence. Critically, no evidence supports transmission through handling or consuming poultry products, and documented human-to-human spread remains exceedingly rare, suggesting that person-to-person transmission, if it occurs, is epidemiologically insignificant.

Risk groups

Source-backed detail is not yet available.

Prevention

No licensed human vaccine exists for psittacosis, rendering exposure prevention the sole protective strategy. Public health recommendations emphasize hand hygiene after bird contact, wetting contaminated surfaces before cleaning to prevent aerosol generation, and avoiding dry sweeping or vacuuming of potentially infected material. Personal protective equipment including gloves and appropriate respiratory masks should be worn when handling birds suspected of infection or cleaning their enclosures. Avian control measures complement human prevention efforts and include avoiding bird overcrowding, maintaining physical separation between cages, isolating and treating infected birds, and implementing regular cleaning protocols for cages and feeding implements. These integrated approaches reduce both environmental contamination and human exposure risk.

Surveillance note

Psittacosis presents surveillance challenges due to its nonspecific clinical presentation, which mimics other causes of atypical pneumonia including Mycoplasma, Legionella, and viral respiratory infections. Routine microbiologic testing protocols in many clinical settings do not include Chlamydia psittaci screening, contributing to underdiagnosis and incomplete case ascertainment. Diagnosis typically requires specialized testing—serology, polymerase chain reaction assays, or advanced metagenomic sequencing in complex cases—limiting surveillance sensitivity in resource-constrained settings. Clinicians should maintain a high index of suspicion for patients with pneumonia and recent bird exposure history, as targeted diagnostic inquiry can improve case detection. Occupational case clustering around aviculture, pet retail, and poultry processing facilities may signal lapses in exposure control and warrant investigation.

Coding Register
ICD-10
ICD-11
Key Statistics
Total cases
2K
Peak month
2002-06
Coverage
3 reporting countries · 2000-01-01 → 2026-05-09

Figure 1 | Full historical trajectories across all reporting countries.

Figure 2 | Year-over-year monthly comparison for seasonality and structural shifts.

Dataset Archive

Supplementary Data | Multi-country disease dataset

Machine-readable multi-country disease dataset (JSON/CSV) with source metadata.

Rows
1,258
Data Version
2026-05-09
Coverage
Included metadata
Source links, scope, cadence

Source Register

Official sources and update cadences used to construct the downloadable dataset.

AU
Australia NINDSSmonthlymicrosoft_bi

Australia

Australian national notifiable diseases surveillance dashboard.

Official source
JP
JP NIID Weeklyweeklyweb

Japan

Japan weekly infectious disease surveillance via NIID/JIHS.

Official source
US
US CDC NNDSSweeklyapi

United States

CDC National Notifiable Diseases Surveillance System provisional data.

Official source
Suggested presentation pattern: cite the data version and coverage window when exporting charts or tables for publication.